Drugs licences to go costlier with this proposed government rule
Advertisement
Advertisement
If a new proposal by the Multi-fold fee hike for product registrations, manufacturing and product licences and clinical trials have been proposed by the Ministry of Health and Family Welfare. The Central government thinks that this is the right time to change the rules, keeping in mind the international rates of drug licensing. However, the
As per provisions, the consultations would be done within six months from date of publication of rules.
Talking of the proposal, it asks for more than six-fold increase in the site registrations, from $1,500 to $10,000. Product registrations, on the other hand, would jump to $5,000 from $1,000.
For local manufacturing and loan licence, the fees will jump more than eight-fold to Rs 50,000 from Rs 6,000 while for site inspections, charges will increase 10-fold to Rs 15,000. There would be a tenfold increase in the fees for a licence to import drugs, which would jump to Rs 10,000 from Rs 1,000. Regarding the registration of a new drug, fees proposed will increase five-fold, from Rs 50,000 to Rs 250,000.
Advertisement
With these new changes, however, the “Make In India” initiative is set to suffer, at least in the pharmaceutical industry.
Image source
Advertisement
- Should you be worried about the potential side-effects of the Covishield vaccine?
- India T20 World Cup squad: KulCha back on menu, KL Rahul dropped
- Sales of homes priced over ₹4 crore rise 10% in Jan-Mar in top 7 cities: CBRE
- Gold prices fluctuate as geopolitical tensions ease; US Fed meeting, payroll data to affect prices this week
- Best beaches to visit in Goa in 2024